v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Series C Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at the beginning at Dec. 31, 2023 $ 18,718              
Balance at the beginning (in shares) at Dec. 31, 2023 1,209,000              
Increase (Decrease) in Temporary Equity Deficit                
Issuance of Series C convertible preferred stock for cash $ 8,201              
Series C convertible preferred stock conversion (in shares) (1,529,000)              
Series C convertible preferred stock conversion $ (14,091)              
Issuance of Series C convertible preferred stock for cash (in shares) 758,000              
Issuance of Series C preferred stock for conversion of debt and accrued interest (in shares) 535,000              
Issuance of Series C preferred stock for conversion of debt and accrued interest $ 2,679              
Balance at the end at Dec. 31, 2024 $ 15,507              
Balance at the end (in shares) at Dec. 31, 2024 972,794              
Balance at the beginning at Dec. 31, 2023   $ 1,175 $ 1,291,316   $ (79) $ (1,359,721) $ 1,536 $ (65,773)
Balance at the beginning (in shares) at Dec. 31, 2023   1,175,459,000            
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 38 14,053         14,091
Series C convertible preferred stock conversion (in shares)   38,237,000            
Issuance of common stock for cash, net   $ 50 13,967         14,017
Issuance of common stock for cash, net (in shares)   50,483,000            
Warrants exercised for cash   $ 7 1,528         1,535
Warrants exercised for cash (in shares)   6,492,000            
Cashless warrants and stock options exercise   $ 3 (3)          
Cashless warrants and stock options exercise (in shares)   3,053,000            
Issuance of common stock for conversion of debt and accrued interest   $ 53 19,355         19,408
Issuance of common stock for conversion of debt and accrued interest (in shares)   52,961,000            
Stock-based compensation     3,456         3,456
Stock-based compensation (in shares)   350,000            
Issuance of common stock as commitment fee (in shares)   1,587,000            
Issuance of common stock as commitment fee   $ 2 498         500
Warrant modifications     2,971         2,971
Deemed dividend related to warrant modifications     (1,414)         (1,414)
Reclassification of equity classified warrants to liabilities     (1,007)         (1,007)
Net loss           (83,778)   (83,778)
Cumulative translation adjustment $ 0 0 0 $ 0 0 0 1,507 1,507
Balance at the end at Dec. 31, 2024   $ 1,328 1,344,720   (79) (1,443,499) 3,043 (94,487)
Balance at the end (in shares) at Dec. 31, 2024   1,328,622,000            
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) (189,000)              
Series C convertible preferred stock conversion $ (2,797)              
Balance at the end at Dec. 31, 2025 $ 12,710              
Balance at the end (in shares) at Dec. 31, 2025 784,347              
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 5 2,792         2,797
Series C convertible preferred stock conversion (in shares)   4,711,000            
Issuance of common stock for cash, net   $ 88 19,231         $ 19,319
Issuance of common stock for cash, net (in shares)   88,134,000           88,100,000
Warrants exercised for cash     23         $ 23
Warrants exercised for cash (in shares)   104,000            
Issuance of common stock for conversion of debt and accrued interest   $ 146 36,881         37,027
Issuance of common stock for conversion of debt and accrued interest (in shares)   145,712,000            
Stock-based compensation     1,207         1,207
Stock-based compensation (in shares)   150,000            
Reclassification of liability classified warrants to equity     5,175         5,175
Warrant modifications     1,315         1,315
Deemed dividend related to warrant modifications     (1,315)         (1,315)
Common shares returned from acquisition     12 $ (12)        
Common shares returned from acquisition (in shares)       (12,000,000)        
Equity contribution from acquisition of Advent     35,432         35,432
Reclassification of equity classified warrants to liabilities     (2,643)         (2,643)
Net loss           (60,162)   (60,162)
Cumulative translation adjustment             (3,968) (3,833)
Balance at the end at Dec. 31, 2025   $ 1,567 $ 1,455,690 $ (12) $ (79) $ (1,503,661) $ (925) $ (60,280)
Balance at the end (in shares) at Dec. 31, 2025   1,567,433,000            
Balance at the end (in shares) at Dec. 31, 2025       (12,000,000)       12,000,000